BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety and Efficacy in Clinical Trials

  The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas, including cardiac studies and for MACE committees.

  December 1, 2017

   · 

  4 min read
• Policy

  Roche Supports FDA Communication About Potential for Biotin Interference With Lab Tests

  Roche supports the recommendation issued by the FDA that patients should report if they are taking biotin as a supplement to their health care providers as part of their patient profile

  December 1, 2017

   · 

  4 min read
• LightIntegra Secures $3.5M Round of Financing

  “The financing allows our company to generate working capital while maintaining its existing ownership structure.”

  December 1, 2017

   · 

  1 min read
• Biotech Bay

  Amarantus Provides Comprehensive Corporate Update

  The Company is focused on its capital restructuring efforts and restarting operations in Q1 2018.

  December 1, 2017

   · 

  17 min read
• Biotech Bay

  NeuroPace Launches New RNS Tablet at 2017 American Epilepsy Society Annual Meeting

  The Tablet will be on display and available for use during hands-on workshops at the American Epilepsy Society’s (AES) Annual Meeting in Washington D.C. from December 1-5 at booth 1101.

  December 1, 2017

   · 

  3 min read
• Business

  Bioclinica Appoints David Herron as CEO

  With more than 10 years’ of experience at Bioclinica, David Herron has led the company’s Medical Imaging business to great success

  December 1, 2017

   · 

  3 min read
• Vilacto Bio Issues Statement About Promotional Activity Concerning Its Common Stock

  The Company is not affiliated in any way with the authors of the promotional activity identified by OTC Markets.

  December 1, 2017

   · 

  3 min read
• Biotech Bay

  Global Blood Therapeutics Announces New Employment Inducement Grants - Dec. 1, 2017

  The first employee received an option to purchase 15,000 shares of the Company’s common stock with a per share exercise price of $39.25, the closing trading price on the grant date of November 28, 2017.

  December 1, 2017

   · 

  1 min read
• Business

  Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory Board

  Dr. Ali joins a distinguished group of oncologists and immunologists providing their expertise and guidance.

  December 1, 2017

   · 

  2 min read
• Catalyst Pharmaceuticals Announces Closing of Previously Announced Public Offering - Dec. 1, 2017

  Piper Jaffray & Co. acted as the lead bookrunner. SunTrust Robinson Humphrey, Inc. also acted as a bookrunner.

  December 1, 2017

   · 

  3 min read